Non-drug therapies for cognitive impairment
نویسندگان
چکیده
منابع مشابه
Emerging Drug Therapies for Heart Failure
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...
متن کاملEmerging therapies for vascular dementia and vascular cognitive impairment.
BACKGROUND Cerebrovascular disease (CVD) and ischemic brain injury secondary to cardiovascular disease are common causes of dementia and cognitive decline in the elderly. CVD also contributes to cognitive loss in Alzheimer disease (AD). SUMMARY Progress in understanding vascular cognitive impairment (VCI) and vascular dementia (VaD) has resulted in promising symptomatic and preventive treatme...
متن کاملTherapeutic Strategies and Drug Development for Vascular Cognitive Impairment
Eric E. Smith, MD, MPH; Alicja Cieslak, MD, MSc; Philip Barber, MD; Jerry Chen, MD; Yu-Wei Chen, MD, PhD; Ida Donnini, MD; Jodi D. Edwards, PhD; Richard Frayne, PhD; Thalia S. Field, MD; Janka Hegedus, MD, PhD; Victoria Hanganu, MD; Zahinoor Ismail, MD; Jamila Kanji, BSc; Makoto Nakajima, MD; Raza Noor, MD; Stefano Peca, PhD; Demetrios Sahlas, MD; Mukul Sharma, MD, MSc; Luciano A. Sposato, MD, ...
متن کاملImprovement of Cognitive Impairment and Hallucination by Pharmacological and Non-pharmacological Therapies for a Parkinsonism’s Disease with Dementia
We reported a case of 80-years-old man with Parkinsonism Disease Dementia (PDD) who experienced an improvement of hallucination with decreasing dose of madopar and non-pharmacological therapies. The patient was initially diagnosed as Parkinson’s disease (PD) 15 years ago, and was medicated with madopar (dose of 250mg per day). The dose of madopar was gradually increased to 375mg per day during ...
متن کاملMelatonin for cognitive impairment.
BACKGROUND There are a number of studies that suggest a relationship between decline of melatonin function and the symptoms of dementia. OBJECTIVES The review assessed the evidence of clinical efficacy and safety of melatonin in the treatment of manifestations of dementia or cognitive impairment (CI). SEARCH STRATEGY The Cochrane Dementia and Cognitive Improvement Group's Specialized Regist...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology, Neuropsychiatry, Psychosomatics
سال: 2019
ISSN: 2310-1342,2074-2711
DOI: 10.14412/2074-2711-2019-3s-68-77